P499: Genetic testing utilization among pediatric heart transplant recipients: A retrospective case series

Genetics in Medicine Open 2026 Open access

Read full text
Authors: Sandra Tomas, Annie Niehaus, Christina G. Tise, Seth A. Hollander, Beth D. Kaufman, Brendan J. Floyd
DOI: 10.1016/j.gimo.2026.103991
Cited by: 0

Abstract

Cardiomyopathies (CM) and congenital heart disease (CHD) are the predominant causes of pediatric heart failure, which in the most profound cases can progress to the need for heart transplantation. The American Heart Association recommends genetic evaluation for all children diagnosed with CM or CHD, as identification of a genetic etiology can provide prognostic information and inform medical decision-making. Despite major advances in genetic testing technologies and increased clinical availability, it remains unclear whether genetic testing is sufficiently utilized in pediatric cardiovascular care.

Fields of Study & Subjects

Cardiomyopathy and Myosin Studies Genomics and Rare Diseases Transplantation: Methods and Outcomes

Publication details

Journal / source
Genetics in Medicine Open
Volume
4
Pages
103991–103991
Publication date
1 January 2026
Language
EN